Navigation Links
Johnson & Johnson Highlights Pharmaceutical Growth Strategies and Robust Pipeline to Address Unmet Medical Needs
Date:6/4/2009

Early stage compounds and new filings targeted in five therapeutic areas

Expanding indications for strong core products builds "pipeline in a product"

Leveraging global capabilities and reach drives growth efforts in emerging markets

Biomarkers and diagnostics combine with therapies to advance personalized medicine

Company's vision focuses on improving human health and reducing global burden of disease

NEW BRUNSWICK, N.J., June 4 /PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE: JNJ) will be reviewing the growth strategies and pipeline for its Pharmaceutical business at a meeting with the investment community today. Senior leaders from the company's pharmaceutical segment will outline how continued expansion of its core products, progress in its pipeline, and an end-to-end approach to its research and development (R&D) will fuel its long-term growth and address unmet medical needs.

The company will highlight its plans for addressing these needs in five therapeutic areas:

  • Neuroscience -- Johnson & Johnson is a leader in neuroscience, which not only includes central nervous system (CNS) disorders, but also treatment of pain -- both acute and chronic. The company will continue to focus on its traditional areas of strength and high unmet need -- schizophrenia, epilepsy, bipolar disorder and pain -- while taking a different approach to neuroscience drug development, including greater emphasis in the future on cognition and dementia.

  • Cardiovascular disease and Metabolism -- In this area, the company is focused on three major conditions -- cardiovascular disease, diabetes, and obesity -- where incidence rates are soaring, placing a trem
    '/>"/>

SOURCE Johnson & Johnson
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Johnson & Johnson Files Arbitration Demand Against Schering-Plough to Resolve Dispute Over Agreements for REMICADE(R) and SIMPONI(TM)
2. Boston Scientific Announces Two Directors Leave Board as Burns Named CEO of Xerox and Johnson Confirmed as Under Secretary of Energy
3. Champions Shawn Johnson & Phil Jackson Wear Energy Muse Jewelry
4. Johnson & Johnson to Participate in Deutsche Bank 34th Annual Health Care Conference
5. Johnson & Johnson to Host Analyst Conference Call To Review Six-Month Trial Results From NEVO RES I
6. EF Johnson Technologies, Inc. Announces First Quarter 2009 Financial Results
7. Johnson & Johnson to Participate in Bank of America and Merrill Lynch 2009 Health Care Conference
8. Weill Cornell and Cornells Johnson School present first annual business and medicine symposium
9. Johnson & Johnson to Webcast Annual Meeting of Shareholders
10. Johnson & Johnson Reports 2009 First-Quarter Results:
11. Trust for Americas Health Supports Recommendations from Robert Wood Johnson Foundation Commission to Build a Healthier America
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2013)... Forney, United States (PRWEB) May 25, 2013 ... oldest and largest underground shelter company in the ... and composite underground structures for over 35 years. ... of PROTECTION, U.S. Handbook of NBC Weapon Fundamentals ... is the United States’ bible on shelter engineering. ...
(Date:5/25/2013)... (PRWEB) May 25, 2013 Absolute Surgical Specialists, ... many of the NALA’s businesses throughout the country participating in ... to participate in the nationwide event as he understands what ... Colonel in the Army. He said, “I wanted to give ... I serve, but I live here too.” , Shop Local ...
(Date:5/25/2013)... 25, 2013 The latest report ... irritable bowel syndrome (IBS) to bloating, constipation, diarrhea ... most long-lasting, embarrassing, frustrating and difficult health issues ... digestive health have provided a cure for ... factors contributing to digestive health issues, a healthy ...
(Date:5/25/2013)... 2013 According to a new ... 2013–2018", published by MarketsandMarkets is expected to reach ... 5.54% which analyzes and studies the major market ... Asia, and Rest of the World. , Browse:, ... , 87 Figures , ...
(Date:5/25/2013)... Vancouver, BC (PRWEB) May 25, 2013 ... of the most beautiful and powerful women that ever ... was felt by some of the most powerful men ... used many beauty remedies to keep her skin glowing ... treatments made with bees- wax, maringa oil and cyprus ...
Breaking Medicine News(10 mins):Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 2Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 3Health News:Dr. Craig Amshel of Absolute Surgical Specialists Offering Bowel Prep During the Shop Local for a Cause Event 2Health News:Natural Foods For Digestive Health Report and Video Published by BetterDigestion.org 2Health News:Homeland Security Market to Reach $544.02 Billion by 2018 at a CARC of 5.54% - New Report by MarketsandMarkets 2Health News:Homeland Security Market to Reach $544.02 Billion by 2018 at a CARC of 5.54% - New Report by MarketsandMarkets 3Health News:Homeland Security Market to Reach $544.02 Billion by 2018 at a CARC of 5.54% - New Report by MarketsandMarkets 4Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 2Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 3
... Profitability, CARLSBAD, Calif., Feb. 12 Genoptix, Inc.,(Nasdaq: ... reported,revenues of $18.6 million for the fourth quarter ended ... $7.8 million for the comparable period,in 2006. For the ... of $59.3 million, an increase of 147% over revenues ...
... Feb. 12 AtriCure, Inc.,(Nasdaq: ATRC ), a ... products, announced today that David J. Drachman, President and,Chief ... Capital,Partners 20th Annual OC Growth Stock Conference at the ... February 20th at 2:00 p.m.,PT., A live web ...
... of anxiety may cause women with ductal carcinoma in ... cancer, to overestimate their risk of recurrence or dying ... at Dana-Farber Cancer Institute in Boston. , "Although DCIS ... DCIS develop inaccurate risk perceptions," said Ann Partridge, MD, ...
... answers the research offers , , TUESDAY, Feb. 12 ... one of the most pressing questions in critical care ... open the partially collapsed lungs of people being treated ... , Unfortunately, that question has not been definitively answered. ...
... cancer specialists at Jeffersons Kimmel Cancer Center in Philadelphia ... for liver cancer. The therapy entails injecting tiny beads ... main artery while also blocking the blood supply feeding ... been approved by the federal Food and Drug Administration ...
... 50, 75 and 100 mcg/hr) Not Affected, ... Pharmaceuticals, Inc. said today that all lots of ... by PriCara in the United States and all ... the United States are being voluntarily,recalled as a ...
Cached Medicine News:Health News:Genoptix Reports Strong Financial Results for the Fourth Quarter and Full Year 2007 2Health News:Genoptix Reports Strong Financial Results for the Fourth Quarter and Full Year 2007 3Health News:Genoptix Reports Strong Financial Results for the Fourth Quarter and Full Year 2007 4Health News:Genoptix Reports Strong Financial Results for the Fourth Quarter and Full Year 2007 5Health News:Genoptix Reports Strong Financial Results for the Fourth Quarter and Full Year 2007 6Health News:Genoptix Reports Strong Financial Results for the Fourth Quarter and Full Year 2007 7Health News:Genoptix Reports Strong Financial Results for the Fourth Quarter and Full Year 2007 8Health News:AtriCure to Present at Roth Capital Partners 20th Annual OC Conference 2Health News:Anxiety linked to newly diagnosed DCIS patients' overestimation of breast cancer risks 2Health News: Respiratory Distress Treatment Studies Conflict 2Health News: Respiratory Distress Treatment Studies Conflict 3Health News:New Jefferson trial to test radiation-emitting beads against advanced liver cancer 2Health News:PriCara(TM) Recalls 25 mcg/hr DURAGESIC(R) (fentanyl transdermal system) CII Pain Patches 2
(Date:5/24/2013)...  BD (Becton, Dickinson and Company) (NYSE: BDX ... it will present at the Deutsche Bank 38 th ... 10:40 a.m. (ET). A live webcast of ... at www.bd.com/investors and will be available for replay ... BD is a leading global medical technology company ...
(Date:5/24/2013)... 24, 2013 Solta Medical, Inc. (NASDAQ: ... today reported Dr. Edward W. Knowlton ... Directors effective immediately.  Dr. Knowlton is the founder of Thermage, ... a director since 1996. "On behalf of the ... I would like to thank Ed for his tireless dedication ...
(Date:5/24/2013)... , May 24, 2013  Heska Corporation (NASDAQ: HSKA, "Heska" ... specialty products, announced today that Dr. Robert Grieve ... Jason Napolitano , executive vice president and ... MicroCap Conference, which is being held May 30, 2013 in ... Hyatt Hotel. The Company,s presentation is scheduled ...
Breaking Medicine Technology:Dr. Edward W. Knowlton Resigns as a Director of Solta Medical, Inc. 2Heska Corporation To Present At The Second Annual Marcum LLP MicroCap Conference 2
... as Associate MemberWASHINGTON, Jan. 13 The Association ... clinical outsourcing industry to regulators, biopharmaceutical clients, policy ... worldwide, today announced that it has elected Dr. ... William Sharbaugh as Chair-Elect. Dr. Winstanly, MBChB, Executive ...
... /PRNewswire-FirstCall/ - - Uroplasty, Inc. (Amex: ... study of Macroplastique for the treatment of female stress ... Journal of Urology . This is the first, large, ... Macroplastique to another bulking agent used in the control ...
Cached Medicine Technology:Dr. Derek Winstanly of Quintiles to Serve as 2009 ACRO Chair; Mr. William Sharbaugh of PPD to Be Chair-Elect 2Uroplasty Highlights Results From Clinical Study on Macroplastique(R) for the Treatment of Stress Urinary Incontinence 2Uroplasty Highlights Results From Clinical Study on Macroplastique(R) for the Treatment of Stress Urinary Incontinence 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: